Laboratory test services provider, Quest Diagnostics Inc. (NYSE: DGX) expects fiscal third quarter profit to miss analysts’ estimation. The Company cited drop in number of tests ordered during the latter part of the quarter for a downbeat guidance. Quest Diagnostics now expects non-GAAP earnings of $1.02 a share down from its earlier projection of $1.15 a share. Analysts had forecasted earnings of $1.20 a share. The Company also anticipates revenue from continuing operations to come at $1.79 billion, which is below analysts’ expectation of $1.84 billion.
Recent Comments